Fulgent Genetics Q2 Revenue USD 85.389 Million
FLGT•Fulgent Genetics reports second-quarter revenue and profit metrics
Jul 30 (Reuters) - Fulgent Genetics Q2 operating expenses USD 61.752 million.
- Q2 operating income USD -36.073 million
- Q2 gross profit USD 25.679 million
- Q2 pretax profit USD -29.69 million
- Q2 adjusted EBITDA USD -17.1 million




